SCHEMBL789432

SCHEMBL789432

COc1ncc(B2OC(C)(C)C(C)(C)O2)cc1NS(=O)(=O)Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALPL P05186 1/20 0.52
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 2/20 0.46
MAPK1 P28482 1/20 0.45
PTK2B Q14289 1/20 0.45
DGAT1 O75907 1/20 0.43
BRAF P15056 1/20 0.41
PDGFRB P09619 1/20 0.40
KDR P35968 1/20 0.40
HPGD P15428 1/20 0.40
CYP17A1 P05093 1/20 0.39
GLO1 Q04760 1/20 0.38
PIK3CG P48736 1/20 0.38
ACLY P53396 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14860356 0.86 ALPL (0.53) ALPLALDH1A1KDM4EDGAT1BRAF
SCHEMBL29556839 0.84 ALPL (0.56) ALPLPDGFRBKDRHPGDPIK3CG
SCHEMBL790824 0.84 ALPL (0.56) ALPLPDGFRBKDRHPGDPIK3CG
SCHEMBL798867 0.84 ALPL (0.48) ALPLDGAT1PDGFRBKDRPIK3CG
SCHEMBL789687 0.82 ALPL (0.47) ALPLDGAT1BRAFPDGFRBKDR
SCHEMBL109782 0.81 ALPL (0.52) ALPLPIK3CG
SCHEMBL789976 0.81 ALPL (0.46) ALPLDGAT1PDGFRBKDRCYP17A1
SCHEMBL790434 0.79 ALPL (0.54) ALPLBRAFPDGFRBKDRCYP17A1
SCHEMBL23275716 0.79 KDM4E (0.44) ALPLALDH1A1KDM4EDGAT1PDGFRB
SCHEMBL30333038 0.78 ALPL (0.58) ALPLBRAFPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012174312-A2 BENZIMIDAZOLE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-12-20 WO disclosed
WO-2012037108-A1 AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-03-22 WO disclosed
WO-2012037108-A1 AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-03-22 WO disclosed